According to a recent analysis by Reports and Data, the Global Cell Therapy Market size is forecast to exceed USD 8.75 Billion in terms of annual remunerations from USD 5.79 in 2019, at a growth rate of 5.6% through 2027. The increasing prevalence of target disease and growing demand for precision medicine is driving cell therapy market trends.
Companies profiled in the Global Cell Therapy Market are:
- JCR Pharmaceuticals Co. Ltd.
- Kolon TissueGene, Inc.
- Fibrocell Science, Inc.
- PHARMICELL Co., Ltd.
- Osiris Therapeutics, Inc.
- MEDIPOST
- Cells for Cells
- Stemedica Cell Technologies, Inc.
- ANTEROGEN Co., Ltd.
- Vericel Corporation
To Get Sample Copy of Report visit @ https://www.reportsanddata.com/sample-enquiry-form/3269
Cell therapy is gaining massive popularity as it has been observed to induce profound healing activity in humans with various kinds of autoimmune disorders. It also has the unique ability to modulate the immune system while preserving its disease fighting ability. Cell therapies are extensively used in regenerative medicine application, especially for immunogenic and degenerative pathologies. Some of the common type of cell therapy are blood transfusion, transfusion of white or red blood cells, and platelets transfusion from a donor. The transplantation of hematopoietic stem cells to create bone marrow is another important cell therapy this is being extensively utilized.
Cell Therapy Market: Segmentation
For the purpose of this report, Reports and Data has segmented the Global Cell Therapy Market on the basis of therapy type, therapeutic area, cell type, end-user, and region:
Therapy Type Outlook (Revenue, USD Billion; 2017-2027)
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
Cell Type Outlook (Revenue, USD Billion; 2017-2027)
- Stem Cells
- Non-Stem Cells
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Academic & Research Institutes
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Rest of MEA
To get a Discount on the Cell Therapy Market Report, Click @ https://www.reportsanddata.com/discount-enquiry-form/3269
With favourable government initiatives, stem cell banking trend is gaining traction. In the developing nations, the number of stem cell banks are expanding at a rapid pace. The increasing awareness regarding the storage of stem cells is likely to positively impact cell therapy industry growth. Moreover, the introduction of advanced genomic analysis techniques and a rise in clinical trials across the globes may also supplement cell therapy market share over the forecast period. However, manufacturing & pharmacological issues, and strict regulatory scenario may hinder market growth.
Based on therapy type, the allogeneic stem cell therapy segment is forecast to contribute significantly to the market revenue share through 2027 due to rising cases of cancer relapse. The allogeneic stem cell therapy is generally prescribed to patients having a high risk of relapse after successful treatment of chemotherapy. This therapy enables the human body to produce immune stem cells to eliminate cancer cells, even if some are left after a high-dose of cytotoxic drug treatment. Increasing prevalence of cancer will positively impact segmental growth.
Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/cell-therapy-market
In terms of end-use, the hospitals and clinics segment is expected to register a CAGR of 5.8% through 2027 due to a rise in the number of pipeline projects over the past few years. The Cancer Research Institute estimates that the number of pipeline projects reached 1,011 in 2019 from 753 in 2018.
Geographically, North America is forecast to dominate the cell therapy industry with a significant revenue share through 2027 due to a huge amount of funding by private and government firms for clinical trials. Asia Pacific is projected to register a growth rate of 6.7%, accounting for 21.8% of the market share through 2027 due to the high prevalence of cancer and an associated demand for cell therapies. Europe is forecast to hold 25.9% of market share during the analysis period.
Key Features of the Cell Therapy Market Report:
- The report encompasses Cell Therapy market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
- An in-depth analysis of the different approaches and procedures undertaken by the key players to conduct business efficiently
- Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
- Supply chain analysis along with technological advancements offered in the report
- The report provides an extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Cell Therapy industry
Connect with an expert for customization of Report @ https://www.reportsanddata.com/request-customization-form/3269
Have a Look at Related Reports:
Prostate-Specific Antigen (PSA) Testing Market Size, Share & Analysis, By Types (CLIA Method, ELISA Method, Others), By Application (Screening, Post-Treatment Monitoring), By Region, Forecast To 2027
Cancer Diagnostics Market Size, Share & Analysis, By Test Type (Imaging, Laboratory Test, Genetic Test, Biopsy, Endoscopy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Ovarian Cancer, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Research Institutes, Others), And Region, Segment Forecasts To 2027
Facial Erythema Therapeutics Market Size, Trends & Analysis By Drug Type (Antibiotics, Antifungal, Antihistamines, Corticosteroids), By Mode of Administration (Topical and Oral), By Region, Forecast to 2027
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
